Pulmonary hypertension (PH) is caused by many disorders that affect the pulmonary vasculature. A recent study has provided evidence that pulmonary vascular remodeling and PH can be observed in lung cancer, and this may be associated with tumor cell–immune cell inflammatory crosstalk. These findings highlight the pressing need to understand better and manage pulmonary vascular comorbidities in lung cancer.

中文翻译：

---

肺癌的肺部合并症

肺动脉高压（PH）是由许多影响肺血管的疾病引起的。最近的一项研究提供了证据，表明在肺癌中可以观察到肺血管重塑和PH值，这可能与肿瘤细胞免疫细胞的炎症串扰有关。这些发现凸显了迫切需要更好地了解和管理肺癌的肺血管合并症。